Matica Enterprises subsidiary, RoyalMax Biotechnology Canada, has received approval from Health Canada for its amended Sales Licence. The Sales Licence permits for the sale of cannabis products to all authorized provincial and territorial distributors/retailers and registered medical patients throughout all of Canada.
“Since the amendment for the Sales Licence was submitted in March of this year, Matica and RoyalMax have been in contact with provincial authorities to begin preparations for retail sales of our small batch crafted product,” states Matica CEO Boris Ziger. “In addition to exceptionally grown Montreal cannabis the Company intends to follow up with an additional product mix. We are planning to introduce pre-roll products, a variety of edibles and an exceptional topical cream created for us by Montreal’s Yunify Natural Technologies. Exciting times indeed,” continues Mr. Ziger.
For more information:
Matica Enterprises
maticaenterprises.com